sebov-detection

Prolonged-term wildlife mortality surveillance in northern Congo: a model for the detection of Ebola virus sickness epizootics.

Ebolavirus (EBOV) has precipitated sickness outbreaks taking tons of of lives, costing billions of {{dollars}} in administration efforts and threatening good ape populations. EBOV ecology should not be completely understood nonetheless contaminated wildlife and consumption of animal carcasses have been linked to human outbreaks, notably inside the Congo Basin.
Partnering with the Congolese Ministry of Nicely being, we carried out wildlife mortality surveillance and educational outreach inside the northern Republic of Congo (RoC). Designed for EBOV detection and to alert public properly being authorities, we established a low-cost wildlife mortality reporting group masking 50 000 km2.
Concurrently, we delivered educational outreach promoting behavioural change to over 6600 people in rural northern RoC. We achieved specimen assortment by teaching enterprise employees on a protected sampling protocol and equipping geographically distributed bases with sampling kits.
We established in-country diagnostics for EBOV testing, reducing diagnostic turnaround time to a few days and demonstrated the absence of EBOV in 58 carcasses. Central Africa stays a high-risk EBOV space, nonetheless RoC, home to crucial remaining populations of good apes, has not had an epidemic since 2005.
This effort continues to function as an untested early warning system in RoC, the place people and good apes have died from earlier Ebola virus sickness outbreaks. This textual content is part of the theme topic ‘Dynamic and integrative approaches to understanding pathogen spillover’.
sebov-detection

sebov-detection

PSMB8 antibody

70R-19589 50 ul
EUR 522
Description: Rabbit polyclonal PSMB8 antibody

PSMB8 Antibody

1-CSB-PA116429
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100

PSMB8 Antibody

1-CSB-PA018886GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF

PSMB8 Antibody

1-CSB-PA018886LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

PSMB8 Antibody

1-CSB-PA775839
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100

PSMB8 Antibody

E94054 100μg
EUR 255
Description: Available in various conjugation types.

PSMB8 Antibody

E97340 100ul
EUR 255
Description: Available in various conjugation types.

PSMB8 Antibody

E043134 100μg/100μl
EUR 255
Description: Available in various conjugation types.

PSMB8 Antibody

E314816 100ug/200ul
EUR 295
Description: Available in various conjugation types.

PSMB8 Conjugated Antibody

C43134 100ul
EUR 476.4

PSMB8 Polyclonal Antibody

A73468
  • EUR 377.30
  • EUR 577.50
  • 50 ul
  • 100 ul

PSMB8 Antibody, HRP conjugated

1-CSB-PA018886LB01HU
  • EUR 380.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

PSMB8 Antibody, FITC conjugated

1-CSB-PA018886LC01HU
  • EUR 380.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

PSMB8 Antibody, Biotin conjugated

1-CSB-PA018886LD01HU
  • EUR 380.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

Monoclonal PSMB8 Antibody, Clone: 1A5

AMM02864G 0.1ml
EUR 633.6
Description: A Monoclonal antibody against Human PSMB8. The antibodies are raised in Mouse and are from clone 1A5. This antibody is applicable in WB and IHC, ICC, E

Mouse Monoclonal Antibody to PSMB8

E10-30255 100ul
EUR 225
Description: Available in various conjugation types.

Psmb8/ Rat Psmb8 ELISA Kit

ELI-15652r 96 Tests
EUR 1063.2

PSMB8

E8EM1709-54 100ul
EUR 275
Description: Available in various conjugation types.

PSMB8

enz-670 5µg
EUR 60
Description: Recombinant Human Proteasome Subunit Beta Type 8

Proteasome subunit beta type-8 (PSMB8) Antibody

20-abx211178
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Proteasome subunit beta type-8 (PSMB8) Antibody

20-abx211851
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Proteasome Subunit Beta Type-8 (PSMB8) Antibody

20-abx141396
  • EUR 444.00
  • EUR 727.20
  • EUR 360.00
  • 100 ul
  • 200 ul
  • 50 ul

Proteasome Subunit Beta Type-8 (PSMB8) Antibody

20-abx114776
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Proteasome Subunit Beta Type-8 (PSMB8) Antibody

abx028154-400ul 400 ul
EUR 627.6

Proteasome Subunit Beta Type-8 (PSMB8) Antibody

abx028154-80l 80 µl
EUR 343.2

Proteasome Subunit Beta Type-8 (PSMB8) Antibody

20-abx006453
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Proteasome Subunit Beta Type-8 (PSMB8) Antibody

abx011689-100ul 100 ul
EUR 493.2

Monoclonal PSMB8 Antibody (monoclonal) (M01), Clone: 1B3

AMM03954G 0.1mg
EUR 580.8
Description: A Monoclonal antibody against Human PSMB8 (monoclonal) (M01). The antibodies are raised in Mouse and are from clone 1B3. This antibody is applicable in WB, IHC and IF, IP, E

PSMB8 siRNA

20-abx930156
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

PSMB8 siRNA

20-abx930157
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

PSMB8 siRNA

20-abx904317
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

PSMB8 Rabbit pAb

A7340-100ul 100 ul
EUR 369.6

PSMB8 Rabbit pAb

A7340-200ul 200 ul
EUR 550.8

PSMB8 Rabbit pAb

A7340-20ul 20 ul
EUR 219.6

PSMB8 Rabbit pAb

A7340-50ul 50 ul
EUR 267.6

PSMB8 Rabbit pAb

E2507340 100ul
EUR 225
Description: Available in various conjugation types.

PSMB8 Blocking Peptide

BF0434-BP 1mg
EUR 234

PSMB8/LMP7 Mouse mAb

E2220606 100ul
EUR 225
Description: Available in various conjugation types.

PSMB8 protein (His tag)

80R-2608 100 ug
EUR 386.4
Description: Purified recombinant PSMB8 protein

PSMB8 / LMP7 Rabbit pAb

E2382339 100ul
EUR 225
Description: Available in various conjugation types.

Canine PSMB8 ELISA KIT

ELI-15651d 96 Tests
EUR 1113.6

Rat PSMB8 shRNA Plasmid

20-abx984734
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Human PSMB8 shRNA Plasmid

20-abx953843
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Mouse PSMB8 shRNA Plasmid

20-abx971337
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

PSMB8 Recombinant Protein (Rat)

RP222629 100 ug Ask for price

PSMB8 Recombinant Protein (Mouse)

RP165287 100 ug Ask for price

PSMB8 Recombinant Protein (Human)

RP085356 100 ug Ask for price

Psmb8 ORF Vector (Rat) (pORF)

ORF074211 1.0 ug DNA
EUR 607.2

PSMB8 ORF Vector (Human) (pORF)

ORF028453 1.0 ug DNA
EUR 486

Psmb8 ORF Vector (Mouse) (pORF)

ORF055097 1.0 ug DNA
EUR 607.2

[KO Validated] PSMB8 Rabbit pAb

A19933-100ul 100 ul
EUR 492

[KO Validated] PSMB8 Rabbit pAb

A19933-200ul 200 ul
EUR 685.2

[KO Validated] PSMB8 Rabbit pAb

A19933-20ul 20 ul
EUR 265.2

[KO Validated] PSMB8 Rabbit pAb

A19933-50ul 50 ul
EUR 344.4

PSMB8 ELISA Kit (Dog) (OKEH03975)

OKEH03975 96 Wells
EUR 1012.8
Description: Description of target: ;Species reactivity: Dog;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.064 ng/mL

PSMB8 ELISA Kit (Human) (OKEH07770)

OKEH07770 96 Wells
EUR 1310.4
Description: Description of target: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.06ng/mL

PSMB8 ELISA Kit (Human) (OKCD02695)

OKCD02695 96 Wells
EUR 950.4
Description: Description of target: The proteasome is a multicatalytic proteinase complex which is characterized by its ability to cleave peptides with Arg, Phe, Tyr, Leu, and Glu adjacent to the leaving group at neutral or slightly basic pH. The proteasome has an ATP-dependent proteolytic activity. This subunit is involved in antigen processing to generate class I binding peptides. Replacement of PSMB5 by PSMB8 increases the capacity of the immunoproteasome to cleave model peptides after hydrophobic and basic residues. Acts as a major component of interferon gamma-induced sensitivity. Plays a key role in apoptosis via the degradation of the apoptotic inhibitor MCL1. May be involved in the inflammatory response pathway. In cancer cells, substitution of isoform 1 (E2) by isoform 2 (E1) results in immunoproteasome deficiency. Required for the differentiation of preadipocytes into adipocytes.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.117 ng/mL

Human PSMB8 Protein Lysate 20ug

IHUPSMB8PLLY20UG each
EUR 213
Description: Human PSMB8 Protein Lysate 20ug

Proteasome 20S LMP7/PSMB8 Rabbit mAb

A23378 200μL
EUR 323.7
Description: A synthetic peptide corresponding to a sequence within amino acids 864-963 of human ApoER2/LRP8 (Q14114).

Psmb8 sgRNA CRISPR Lentivector set (Rat)

K6921501 3 x 1.0 ug
EUR 406.8

PSMB8 sgRNA CRISPR Lentivector set (Human)

K1740301 3 x 1.0 ug
EUR 406.8

Psmb8 sgRNA CRISPR Lentivector set (Mouse)

K4425601 3 x 1.0 ug
EUR 406.8

Psmb8 3'UTR GFP Stable Cell Line

TU266964 1.0 ml Ask for price

Psmb8 3'UTR GFP Stable Cell Line

TU167173 1.0 ml Ask for price

PSMB8 3'UTR GFP Stable Cell Line

TU069046 1.0 ml
EUR 1672.8

Rabbit Anti Human PSMB8 Monoclonal Clone AEFI-16

IRBAHUPSMB8AEFI16C100UL each
EUR 496
Description: Rabbit Anti Human PSMB8 Monoclonal Clone AEFI-16

PSMB8 Protein Vector (Rat) (pPM-C-HA)

PV296844 500 ng
EUR 723.6

A novel carbon nanoparticle probe-based ultrasensitive lateral circulation assay for quick detection of Ebola virus.

Ebola virus (EBOV) is an terribly contagious pathogen first present in Africa associated to excessive hemorrhagic sickness in individuals and nonhuman primates, which has resulted in at least 28 500 suspected circumstances and 11 300 confirmed deaths in 2014-2016 Ebola epidemic in West Africa.
Speedy and delicate detection of EBOV is the essential factor to rising the likelihood of survival and reducing an an infection costs in pandemic areas. Proper right here, we report an ultrasensitive and instrument-free EBOV detection assay primarily based totally on colloidal carbon immunochromatography.
Carbon nanoparticle-labeled rabbit anti-EBOV-VP40 IgG had been concentrated inside the conjugate pad, monoclonal antibody (McAb, 4B7F9) in the direction of EBOV-VP40 and goat anti-rabbit IgG had been immobilized on the nitrocellulose membrane with 2 μL/cm at a spotlight of 1 mg/mL as check out and administration strains, respectively.
Then the sample software program pad, conjugate launch pad, nitrocellulose membrane and absorbent pad had been assembled proper right into a lateral circulation check out strip.
The check out strip reveals strong specificity in the direction of related viruses that share comparable medical indicators and geographic fluctuate with EBOV, along with marburg virus, influenza virus, yellow fever virus and dengue virus. In addition to, 1 500 damaging serums had been examined with false-positive value of 1.3‰ which significantly lower than that of ReEBOV™ colloidal gold check out bundle helpful by World Nicely being Group (WHO).
The sensitivity of this strip was analyzed using inactivated EBOV with detection prohibit of 100 ng/mL (10⁶ copies/mL) which clearly elevated than that of ReEBOV™ dipstick (10⁸ copies/mL). Furthermore, the strip confirmed wonderful thermal stability traits in room temperature and is likely to be as a point-of-care (POC), ultra-sensitive and specific promising candidate for EBOV serological screening in rural Africa or entry/exit ports.

A Survey of Virus Recombination Uncovers Canonical Choices of Artificial Chimeras Generated All through Deep Sequencing Library Preparation.

Chimeric reads could also be generated by in vitro recombination all through the preparation of high-throughput sequencing libraries.
Our attempt to detect natural recombination between the genomes of dengue virus (DENV; +ssRNA genome) and its mosquito host using the Illumina Nextera sequencing library preparation bundle revealed that almost all, if not all, detected host-virus chimeras had been artificial.
Definitely, these chimeras weren’t further frequent than with administration RNA from one different species (a pillbug), which was certainly not in contact with DENV RNA earlier to the library preparation.
The proportion of chimera varieties merely mirrored these of the three species amongst sequencing reads. Chimeras had been repeatedly characterised by the presence of 1-20 bp microhomology between recombining fragments.
Inside-species chimeras principally involved fragments in reverse orientations and located decrease than 100 bp from each other inside the parental genome.
We found comparable choices in printed datasets using two totally different viruses: Ebola virus (EBOV; -ssRNA genome) and a herpesvirus (dsDNA genome), every produced with the Illumina Nextera protocol. These canonical choices counsel that artificial chimeras are generated by intra-molecular template switching of the DNA polymerase all through the PCR step of the Nextera protocol.
Lastly, a broadcast Illumina dataset using the Flock Residence virus (FHV; +ssRNA genome) generated with a protocol stopping artificial recombination revealed the presence of 1-10 bp microhomology motifs in FHV-FHV chimeras, nonetheless just a few recombining fragments had been in reverse orientations.
Our analysis uncovered sequence choices characterizing recombination breakpoints in short-read sequencing datasets, which can be helpful to guage the presence and extent of artificial recombination.

Influenza A Virus H3N2 Brisbane 10/07

7-07950 1mg Ask for price

Influenza A Virus H3N2 Brisbane 10 / 07 Protein

20-abx260509
  • EUR 276.00
  • EUR 3082.80
  • EUR 393.60
  • 10 ug
  • 1 mg
  • 50 ug

Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen

11-567 0.1 mg
EUR 632.4
Description: Influenza A (A/Brisbane/10/07), Influenza A Virus, Strain A/Brisbane/10/07 (H3N2)

Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen Liquid

IFLUABN1007H3N2ALR100UG each
EUR 738
Description: Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen Liquid

Influenza A H3N2 (A/Brisbane/10/2007) HA protein, His Tag

E40VAG023 20ug
EUR 495

Influenza A H1N1 (A/Brisbane/59/2007) HA protein, His Tag

E40VAG011 20ug
EUR 495

Influenza A H3N2 (A/Brisbane/10/2007) HA Protein (HA1 Subunit), His Tag

E40VAG022 20ug
EUR 495

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide

11-563 0.05 mg
EUR 632.4
Description: Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide

11-564 0.05 mg
EUR 632.4
Description: Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide

Influenza B (B/Brisbane/60/2008) HA protein, His Tag

E40VAG161 20ug
EUR 495

Influenza B (B/Brisbane/60/2008) HA protein, His Tag

E40VAG163 20ug
EUR 495

Influenza A H1N1 (A/Brisbane/59/2007) HA Protein (HA1 Subunit), His Tag

E40VAG010 20ug
EUR 495

Influenza B (B/Brisbane/60/2008) HA Protein (HA1 Subunit), His Tag

E40VAG162 20ug
EUR 495

Influenza B (B/Brisbane/3/2007) HA Protein (HA1 Subunit), His Tag

E40VAG283 20ug
EUR 495

Influenza A H1N1pdm (Brisbane/2/18) Culture Fluid (Heat Inactivated) (1 mL)

0810585CFHI 1 mL
EUR 422

Recombinant Influenza H3N2 Brisbane Protein, Untagged, Insect-10ug

QP12081-10ug 10ug
EUR 186

Recombinant Influenza H3N2 Brisbane Protein, Untagged, Insect-1mg

QP12081-1mg 1mg
EUR 2470.8

Recombinant Influenza H3N2 Brisbane Protein, Untagged, Insect-50ug

QP12081-50ug 50ug
EUR 241.2

Recombinant (HEK) purified Influenza A nucleoprotein (H1N1-NP/1-486aa) protein (A/Brisbane/59/2007, >95%, His-tag)

H1NP26-R-25 25 ug
EUR 416.4

Recombinant (HEK) purified Influenza B HA1 protein (B/Brisbane/60/2008)(aa.16-363, >95%, his-tag)

HA1B012-R-10 10 ug
EUR 343.2

Recombinant (HEK) purified Influenza B HA1 protein (B/Brisbane/60/2008)(aa.16-363, >95%, his-tag)

HA1B012-R-100 100 ug
EUR 927.6

Recombinant (HEK) purified Influenza B HA protein (B/Brisbane/60/2008, ?TM, 16-548aa, >95%, his-tag)

HA1B013-R-10 10 ug
EUR 343.2

Recombinant (HEK) purified Influenza B HA protein (B/Brisbane/60/2008, ?TM, 16-548aa, >95%, his-tag)

HA1B013-R-100 100 ug
EUR 927.6

Influenza A [A/California/07/2009 (H1N1pdm)] Viral Lysate

NAT41634-100 0.1
EUR 512.85
Description: Influenza A H1N1 Pandemic 2009 (H1N1pdm) virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Influenza A [A/California/07/2009 (H1N1pdm)] Viral Lysate

NAT41634-500 0.5
EUR 2181.53
Description: Influenza A H1N1 Pandemic 2009 (H1N1pdm) virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Brisbane 1007

iha-024 10µg
EUR 60
Description: Influenza A Virus H3N2 Brisbane 1007

IAV H3N2 (aa 18-530) (A/Brisbane/10/2007) [His]

DAG1693 50 ug
EUR 2017.2

IAV H3N2 nucleoprotein (A/Brisbane/10/2007) [His]

DAG2329 100 µg
EUR 868.8

Influenza A [A/Hong Kong/8/1968 (H3N2)] Viral Lysate

NAT41641-100 0.1
EUR 523.06
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Influenza A [A/Hong Kong/8/1968 (H3N2)] Viral Lysate

NAT41641-500 0.5
EUR 2181.53
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Influenza A [A/New Caledonia/20/1999 (H1N1)] Viral Lysate

NAT41629-100 0.1
EUR 512.85
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Influenza A [A/New Caledonia/20/1999 (H1N1)] Viral Lysate

NAT41629-500 0.5
EUR 2181.53
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Mouse Monoclonal Anti-Influenza A HA (H3N2, 1-531aa/HA1+HA2) (A/Brisbane/10/2007) protein IgG

H3N21-M 100 ul
EUR 578.4

IAV H3N2 non-structural 1 (A/Brisbane/10/2007 ) [His]

DAG2335 100 µg
EUR 868.8

Rabbit Anti-Influenza A HA (H3N2, 1-531aa/HA1+HA2) (A/Brisbane/10/2007) protein IgG, aff pure

H3N23-A 100 ul
EUR 534

IAV H3N2 Hemagglutinin (aa 17-530) (A/Brisbane/10/2007) [His]

DAG2224 100 µg
EUR 1095.6

IAV H1N1 nucleoprotein (aa 1-486) (A/Brisbane/10/2007) [His]

DAG2328 100 µg
EUR 868.8

IAV H1N1 (aa 18-530) (A/Brisbane/59/2007) [His]

DAG1688 50 ug
EUR 2017.2

IAV H3N2 Hemagglutinin 1 (aa 17-345) (A/Brisbane/10/2007) [His]

DAG2282 100 µg
EUR 1095.6

Influenza A H3 Antibody

abx021977-1mg 1 mg
EUR 1053.6

Influenza A H3 Antibody

abx021978-1mg 1 mg
EUR 1053.6

IAV H1N1 Hemagglutin (aa 51-301) (A/Brisbane/59/2007) [His]

DAG2202 100 µg
EUR 1095.6

IAV H1N1 Hemagglutin (aa 18-530) (A/Brisbane/59/2007) [His]

DAG2220 100 µg
EUR 1095.6

Influenza B [B/Florida/02/2006] Viral Lysate

NAT41648-100 0.1
EUR 523.06
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

IAV H1N1 Hemagglutin 1 (aa 18-343) (A/Brisbane/59/2007) [His]

DAG1775 50 ug
EUR 2017.2

IAV H1N1 Hemagglutin 1 (aa 18-343) (A/Brisbane/59/2007) [His]

DAG2279 100 µg
EUR 1095.6

IAV H3N2 Hemagglutinin 1 (aa 17-346) (A/Brisbane/299/2011 ) [His]

DAG2246 100 µg
EUR 1095.6

Recombinant IAV H1N1 Protein (aa 18-530) (A/Brisbane/59/2007) [His]

VAng-Lsx0333-inquire inquire Ask for price
Description: IAV H1N1 (aa 18-530) (A/Brisbane/59/2007) [His], recombinant protein from HEK 293 cells.

Influenza B [B/Massachusetts/2/2012] Viral Lysate

NAT41653-100 0.1
EUR 523.06
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Influenza B [B/Massachusetts/2/2012] Viral Lysate

NAT41653-500 0.5
EUR 2181.53
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Recombinant IAV H3N2 Hemagglutinin / HA Protein (aa 1-530) [His] (A/Brisbane/10/2007)

VAng-Wyb7007-100g 100 µg
EUR 2089.2
Description: Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin / HA, recombinant protein.

Recombinant IAV H3N2 Hemagglutinin / HA Protein (aa 1-530) [His] (A/Brisbane/10/2007)

VAng-Wyb7007-50g 50 µg
EUR 1260
Description: Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin / HA, recombinant protein.

Influenza A virus H3 PCR kit

PCR-H649-48R 50T
EUR 987.6

Influenza A virus H3 PCR kit

PCR-H649-96R 100T
EUR 1335.6

Recombinant IAV H3N2 Hemagglutinin HA1 Subunit Protein (aa 1-345) [His] (A/Brisbane/10/2007)

VAng-Wyb7063-100g 100 µg
EUR 2089.2
Description: Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin HA1 Subunit, recombinant protein.

Recombinant IAV H3N2 Hemagglutinin HA1 Subunit Protein (aa 1-345) [His] (A/Brisbane/10/2007)

VAng-Wyb7063-10g 10 µg
EUR 687.6
Description: Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin HA1 Subunit, recombinant protein.

Recombinant IAV H3N2 Hemagglutinin HA1 Subunit Protein (aa 1-345) [His] (A/Brisbane/10/2007)

VAng-Wyb7063-50g 50 µg
EUR 1260
Description: Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin HA1 Subunit, recombinant protein.

IBV Hemagglutinin (aa 16-548) (B/Brisbane/60/2008) [His]

DAG2215 100 µg
EUR 1095.6

IBV Nucleoprotein (aa 1-560) (B/Brisbane/60/2008) [His]

DAG2319 100 µg
EUR 868.8

OPPA01552-10UG - H3N2 Brisbane Protein

OPPA01552-10UG 10ug
EUR 70

Influenza A Virus H3 Antigen Antibody

abx415738-01mg 0.1 mg
EUR 861.6

Influenza A virus H3 RT PCR kit

RTq-H649-100R 100T
EUR 1573.2

Influenza A virus H3 RT PCR kit

RTq-H649-150R 150T
EUR 2144.4

Influenza A virus H3 RT PCR kit

RTq-H649-50R 50T
EUR 1155.6

IBV Matrix Proteins 1 (aa 1-252) (B/Brisbane/60/2008) [His]

DAG2304 100 µg
EUR 868.8

IBV Matrix Proteins 1 (aa 1-248) (B/Brisbane/60/2008) [His]

DAG2305 100 µg
EUR 868.8

Recombinant IAV H1N1 Hemagglutinin / HA Protein (aa 1-528) [His] (A/Brisbane/59/2007)

VAng-Wyb6941-100g 100 µg
EUR 2092.8
Description: Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin / HA, recombinant protein.

Recombinant IAV H1N1 Hemagglutinin / HA Protein (aa 1-528) [His] (A/Brisbane/59/2007)

VAng-Wyb6941-10g 10 µg
EUR 687.6
Description: Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin / HA, recombinant protein.

Recombinant IAV H1N1 Hemagglutinin / HA Protein (aa 1-528) [His] (A/Brisbane/59/2007)

VAng-Wyb6941-50g 50 µg
EUR 1260
Description: Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin / HA, recombinant protein.

Influenza A H1N1 (A/Ohio/07/2009) HA protein, His Tag

E40VAG150 20ug
EUR 495

Influenza B Virus Florida 07/04

7-07918 10µg Ask for price

Influenza B Virus Florida 07/04

7-07919 50µg Ask for price

Influenza B Virus Florida 07/04

7-07920 1mg Ask for price

Influenza A H1N1 (A/California/07/2009) HA protein, His Tag

E40VAG044 20ug
EUR 495

Influenza A virus H3 One-Step PCR kit

Oneq-H649-100R 100T
EUR 1932

Influenza A virus H3 One-Step PCR kit

Oneq-H649-150R 150T
EUR 2646

Influenza A virus H3 One-Step PCR kit

Oneq-H649-50R 50T
EUR 1410

Recombinant IBV Hemagglutinin Protein (aa 16-548) (B/Brisbane/60/2008) [His]

VAng-Lsx0372-inquire inquire Ask for price
Description: IBV Hemagglutinin (aa 16-548) (B/Brisbane/60/2008) [His], recombinant protein from HEK 293 cells.

Influenza B (B / Florida / 07 / 04) Protein

abx060630-1mg 1 mg
EUR 2247.6

Influenza B Virus Florida 07 / 04 Protein

20-abx260511
  • EUR 276.00
  • EUR 3082.80
  • EUR 393.60
  • 10 ug
  • 1 mg
  • 50 ug

Recombinant IBV Hemagglutinin / HA1 Protein (aa 1-361) [His] (B/Brisbane/3/2007)

VAng-Wyb7105-100g 100 µg
EUR 2281.2
Description: Influenza B (B/Brisbane/3/2007) Hemagglutinin / HA1, recombinant protein.

Recombinant IBV Hemagglutinin / HA1 Protein (aa 1-361) [His] (B/Brisbane/3/2007)

VAng-Wyb7105-50g 50 µg
EUR 1330.8
Description: Influenza B (B/Brisbane/3/2007) Hemagglutinin / HA1, recombinant protein.

Influenza B Strain B/Florida/07/04 Antigen

11-575 0.1 mg
EUR 632.4
Description: Influenza B (B/Florida/07/04), Influenza B Virus, Strain B/Florida/07/04

Influenza-A H5N1

ant-073 5µg
EUR 60
Description: Mouse Anti-Human H5N1HA1

Influenza-A H3N2

ant-080 5µg
EUR 60
Description: Mouse Anti-Human H3N2HA1

Influenza-A H1N1

ant-214 10µg
EUR 60
Description: Mouse Anti Influenza-A Hemagglutinin H1N1

Influenza-A H3N2

ant-215 10µg
EUR 60
Description: Mouse Anti Influenza-A Hemagglutinin H3N2

Influenza-A H5N1

ant-216 10µg
EUR 60
Description: Mouse Anti Influenza-A Hemagglutinin H5N1